Answer
Spectrila (asparaginase) should not be used during pregnancy unless the woman’s clinical condition requires asparaginase treatment, because there are no data in pregnant women and animal studies with asparaginase preparations showed embryotoxic and teratogenic effects.
Sources for this answer
- Spectrila 10,000 U powder for concentrate for solution for infusionmedac Pharma LLP · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked